HealthTech.euabout 13 hours ago
Tissium raises €30M in equity, €30M in debt
2 min read
French startup Tissium raised €30M in equity and up to €30M in debt financing. The company uses biomorphic programmable polymers to repair tissue without invasive stitches. Two products, for nerve repair and hernia treatment, have FDA approval. The equity round was led by an undisclosed US family-owned institutional investor.
Level
Hype check
Tap to vote and see what everyone thinks.
